Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00454337
Status:
COMPLETED
Last Update Posted:
2012-11-07
First Post:
2007-03-29
Brief Title:
Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load
Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Organization:
ANRS Emerging Infectious Diseases
Organization Data
Organization:
ANRS Emerging Infectious Diseases
Class:
OTHER_GOV
Study ID:
2007-000162-20
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |